Literature DB >> 11849394

Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat.

Anumeet Priyadarshi1, Sankaridrug Periyasamy, Thomas J Burke, Steven L Britton, Deepak Malhotra, Joseph I Shapiro.   

Abstract

BACKGROUND: It is well known that the anemia of chronic renal failure is associated with a blunted erythropoietin response. However, it is not clear why this response is blunted. Oxygen tension is an important regulator of erythropoietin production and release, but the effect of reduced renal mass on renal tissue oxygen tensions is currently unknown.
METHODS: A computer-based simulation was used to determine how alterations in filtration fraction might impact on renal tissue oxygen tensions. In addition, direct measurements of oxygen tension with needle electrodes were employed, as well as conventional physiological measurements and ELISA measurements of plasma and tissue erythropoietin concentrations in rats subjected to 5/6th nephrectomy.
RESULTS: Remnant kidney rats had 39% and 52% decreases in tissue and plasma erythropoietin concentrations, respectively, that correlated with 73% increased oxygen tensions in both cortex and outer medulla in the remnant kidney (all P < 0.01). Estimations of filtration fraction were decreased by approximately 36% in the rats bearing remnant kidneys.
CONCLUSIONS: Higher oxygen tensions were observed in the remnant kidneys. We suggest that higher oxygen tensions are caused by a decrease in filtration fraction, and that these higher tissue oxygen tensions result in decreased renal erythropoietin production and anemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849394     DOI: 10.1046/j.1523-1755.2002.00140.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.

Authors:  Asada Leelahavanichkul; Qin Yan; Xuzhen Hu; Christoph Eisner; Yuning Huang; Richard Chen; Diane Mizel; Hua Zhou; Elizabeth C Wright; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

2.  Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.

Authors:  Wanja M Bernhardt; Michael S Wiesener; Paul Scigalla; James Chou; Roland E Schmieder; Volkmar Günzler; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

3.  Hypoxia in renal disease with proteinuria and/or glomerular hypertension.

Authors:  Tetsuhiro Tanaka; Toshio Miyata; Reiko Inagi; Toshiro Fujita; Masaomi Nangaku
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 4.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

5.  Urinary obstruction depresses erythropoiesis which recovers after parenchyma-saving surgery but not SWL.

Authors:  Davor Eterović; Marijan Situm; Ante Punda; Vinko Marković; Slaven Kokić
Journal:  Urol Res       Date:  2009-12-01

6.  NFAT5 is activated by hypoxia: role in ischemia and reperfusion in the rat kidney.

Authors:  Sandra Villanueva; Cristian Suazo; Daniela Santapau; Francisco Pérez; Mariana Quiroz; Juan E Carreño; Sebastián Illanes; Sergio Lavandero; Luis Michea; Carlos E Irarrazabal
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

7.  Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans.

Authors:  Menno Pruijm; Lucie Hofmann; Maciej Piskunowicz; Marie-Eve Muller; Carole Zweiacker; Isabelle Bassi; Bruno Vogt; Matthias Stuber; Michel Burnier
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 8.  Blood oxygenation level-dependent MRI for assessment of renal oxygenation.

Authors:  Joel Neugarten; Ladan Golestaneh
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-11-21

9.  Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects.

Authors:  Ingo Flamme; Felix Oehme; Peter Ellinghaus; Mario Jeske; Jörg Keldenich; Uwe Thuss
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 10.  Blood Oxygenation Level-Dependent MRI to Assess Renal Oxygenation in Renal Diseases: Progresses and Challenges.

Authors:  Menno Pruijm; Bastien Milani; Michel Burnier
Journal:  Front Physiol       Date:  2017-01-05       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.